Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Oct 24, 2016
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marinus Pharmaceuticals Inc
| -750.68K |
$1.39 | -$1,042,698.68 | -35.31% | 1.38M |
Oct 20
| |||||||
Hyperion Therapeutics Inc
| -1.94M |
$46.00 | -$89,215,804.00 | -100.00% |
0
|
May 7
| |||||||
Marinus Pharmaceuticals Inc
| 2.13M |
$8.00 | $6,005,464.00 | +71.72% | 5.09M |
Aug 5
| |||||||
Marinus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aerie Pharmaceuticals Inc
| -1.01M |
$24.91 | -$24,208,330.17 | -39.15% | 1.57M |
Jul 9 - Jul 10
| |||||||
Hyperion Therapeutics Inc
| -417.75K |
$27.70 | -$11,571,591.90 | -17.72% | 1.94M |
Jun 4
| |||||||
Aerie Pharmaceuticals Inc
| -191.98K |
—
|
—
| -6.94% | 2.57M |
Jun 2
| |||||||
Aerie Pharmaceuticals Inc
| -323.93K |
$16.00 | -$5,182,912.00 | -10.48% | 2.77M |
May 22
| |||||||
Ocera Therapeutics, Inc.
| -410.02K |
—
|
—
| -33.00% | 832.47K |
Mar 18
| |||||||
Hyperion Therapeutics Inc
| -590.00K |
$30.02 | -$709,222.50 | -20.02% | 2.36M |
Mar 3 - Mar 4
|
Scheduled
| ||||||
Aerie Pharmaceuticals Inc
| 3.09M |
$6.49 |
—
|
∞
| 3.09M |
Oct 25
| |||||||
Aerie Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ocera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ocera Therapeutics, Inc.
| 391.17K |
$6.03 | $2,357,322.78 | +45.95% | 1.24M |
Jul 15
| |||||||
Hyperion Therapeutics Inc
| 2.94M |
$10.00 |
—
| +74,816.65% | 2.95M |
Jul 31
| |||||||
Hyperion Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Durata Therapeutics, Inc.
| 2.27M |
$9.00 | $5,294,124.00 | +134.95% | 3.95M |
Jul 24
| |||||||
Trius Therapeutics Inc
| -3.47M |
—
|
—
| -96.00% | 144.65K |
Jan 12
|
Scheduled
| ||||||
Anthera Pharmaceuticals Inc
| 4.07M |
$6.13 | $12,560,454.34 | +30.31% | 17.51M |
Mar 4
| |||||||
Anthera Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Amarin Corp Plc\uk
| -424.90K |
$7.25 | -$3,080,609.98 | -4.75% | 8.51M |
Mar 29
| |||||||
Amarin Corp Plc\uk
| -575.10K |
$7.55 | -$4,341,332.61 | -6.05% | 8.94M |
Mar 24 - Mar 25
| |||||||
Amarin Corp Plc\uk
| -2.00M |
$7.50 | -$15,000,000.00 | -17.37% | 9.51M |
Mar 11
| |||||||
Amarin Corp Plc\uk
| -637.00K |
$7.26 | -$4,622,857.88 | -5.24% | 11.51M |
Mar 9 - Mar 10
| |||||||
Amarin Corp Plc\uk
| -363.00K |
$8.13 | -$2,952,787.20 | -2.90% | 12.15M |
Feb 25
| |||||||
Amarin Corp Plc\uk
|
0
|
—
|
—
|
—
|
0
| ||||||||
Trius Therapeutics Inc
| 3.62M |
$4.68 |
—
|
∞
| 3.62M |
Aug 6
| |||||||
Trius Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Anesiva, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Anesiva, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.